Food Hypersensitivity Clinical Trial
Official title:
Oral Immunotherapy for Peanut and Mammalian Meat Allergies
NCT number | NCT02350660 |
Other study ID # | 15098 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 2012 |
Est. completion date | June 2015 |
Verified date | November 2020 |
Source | University of Virginia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Pilot study to assess the effect of oral immunotherapy on specific Immunoglobulin E (IgE) levels and antigen consumption in two distinct food allergies.
Status | Completed |
Enrollment | 24 |
Est. completion date | June 2015 |
Est. primary completion date | September 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 4 Years to 80 Years |
Eligibility | Inclusion Criteria: - Presence or absence of specific IgE to alpha-gal or peanut Exclusion Criteria: - History of severe anaphylaxis - allergy to cow's milk protein |
Country | Name | City | State |
---|---|---|---|
United States | University of Virginia | Charlottesville | Virginia |
Lead Sponsor | Collaborator |
---|---|
University of Virginia |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The Level of Allergen Consumed Post-oral Immunotherapy | consumption of cow's milk or peanut flour at open challenge. This is a single time-point assessment; not measured repeatedly. | Following 36 months of maintenance oral immunotherapy, participants completed an open challenge at month 37 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01904604 -
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
|
Phase 2 | |
Enrolling by invitation |
NCT04885959 -
The Effects of Traditional Asian Diet on Gut Microbiome and Metabolome in Healthy Volunteers and Pregnancy on Subsequent Infant's Allergy Development
|
N/A | |
Recruiting |
NCT03974555 -
Epidemiological Investigation and Cohort Study on Food Allergy in Children Aged 3 to 6 Years in Wenzhou and Taizhou Urban Areas
|
||
Recruiting |
NCT05177744 -
Toxicity of Micro and Nano Plastics Combined With Environmental Contaminants on the Risk of Allergic Disease
|
||
Completed |
NCT01420705 -
Bacille Calmette-Guérin (BCG) Vaccine and Atopy
|
N/A | |
Completed |
NCT00850668 -
Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults
|
Phase 1 | |
Withdrawn |
NCT00736112 -
Food Allergy - Tubes - Adenoids (FATA) Trial
|
N/A | |
Active, not recruiting |
NCT00298337 -
Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008
|
Phase 2/Phase 3 | |
Completed |
NCT03693456 -
Food Allergy Diagnostic Test Response to Previous Oral Challenge Response
|
N/A | |
Completed |
NCT00461097 -
Oral Immunotherapy for Childhood Egg Allergy
|
Phase 2 | |
Completed |
NCT02606721 -
Food Allergy Challenge Diagnostic Study
|
||
Active, not recruiting |
NCT02457416 -
Take Away Food Allergy; Inducing Tolerance in Children Allergic to Peanut
|
N/A | |
Completed |
NCT02825069 -
Study on the Induction of Food Tolerance in Babies
|
N/A | |
Completed |
NCT01084174 -
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy
|
Phase 1/Phase 2 | |
Completed |
NCT00597675 -
Oral Immunotherapy for Peanut Allergy (PMIT)
|
Phase 2 | |
Completed |
NCT00932828 -
Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study
|
Phase 2 | |
Completed |
NCT01373242 -
Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance
|
Phase 1/Phase 2 | |
Completed |
NCT00578656 -
An Interventional Study of Milk Allergy
|
Phase 0 | |
Completed |
NCT00356174 -
An Observational Study of Childhood Food Allergy
|
N/A | |
Terminated |
NCT02213341 -
Impact of Vaccination on Th2 Immunity in Infancy
|